Valdis Ģībietis1,2,3, Dana Kigitoviča4,5,6, Barbara Vītola4,6, Sintija Strautmane7, Andris Skride5,6. 1. Faculty of Continuing Education, Riga Stradins University, Riga, Latvia, valdisgib@gmail.com. 2. Department of Internal Medicine, Riga Stradins University, Riga, Latvia, valdisgib@gmail.com. 3. Pauls Stradins Clinical University Hospital, Riga, Latvia, valdisgib@gmail.com. 4. Faculty of Continuing Education, Riga Stradins University, Riga, Latvia. 5. Department of Internal Medicine, Riga Stradins University, Riga, Latvia. 6. Pauls Stradins Clinical University Hospital, Riga, Latvia. 7. Faculty of Medicine, Riga Stradins University, Riga, Latvia.
Abstract
BACKGROUND: In-hospital mortality for patients presenting with acute pulmonary embolism (PE) has been reported to be up to 7 times higher for patients with decreased estimated glomerular filtration rate (eGFR). However, few studies have assessed its effect on long-term mortality. OBJECTIVE: To determine the impact of eGFR and creatinine clearance (CrCl) on long-term all-cause mortality following acute PE in association with other routine laboratory analyses and comorbidities. PATIENTS/ METHODS: The prospective study enrolled 141 consecutive patients presenting with objectively confirmed acute PE. Demographic, clinical data, comorbidities, and laboratory values were recorded. CrCl and GFR were estimated using the Cockcroft-Gault, MDRD, and chronic kidney disease (CKD)-EPI equations. Patients were followed up at 90 days and 1 year after the event. RESULTS: In univariate analyses, age, active cancer, PE severity index (PESI), CrCl and eGFR, D-dimer value, and high-density lipoprotein level were found to be significantly associated with mortality in 90 days and 1 year. Additionally, body mass index was significant in the 1-year follow-up. CrCl by Cockcroft-Gault (90-day: area under the curve [AUC] 0.763; 1-year: AUC 0.718) demonstrated higher discriminatory power for predicting mortality than eGFR by the MDRD (AUC 0.686; AUC 0.609) and CKD-EPI (AUC 0.697; AUC 0.630) equations. In multivariate analyses, active cancer, CrCl by Cockcroft-Gault (90-day: hazard ratio [HR] 0.948, 95% CI 0.919-0.979; 1-year: HR 0.967, 95% CI 0.943-0.991), eGFR by CKD-EPI (90-day: HR 0.948, 95% CI 0.915-0.983; 1-year: HR 0.971, 95% CI 0.945-0.998) were found to be independent predictors of mortality. eGFR by MDRD, D-dimer, and PESI value were significant prognostic factors for 90-day mortality. CONCLUSION: Decreased renal function is a prognostic factor for increased all-cause mortality 90 days and 1 year after acute PE.
BACKGROUND: In-hospital mortality for patients presenting with acute pulmonary embolism (PE) has been reported to be up to 7 times higher for patients with decreased estimated glomerular filtration rate (eGFR). However, few studies have assessed its effect on long-term mortality. OBJECTIVE: To determine the impact of eGFR and creatinine clearance (CrCl) on long-term all-cause mortality following acute PE in association with other routine laboratory analyses and comorbidities. PATIENTS/ METHODS: The prospective study enrolled 141 consecutive patients presenting with objectively confirmed acute PE. Demographic, clinical data, comorbidities, and laboratory values were recorded. CrCl and GFR were estimated using the Cockcroft-Gault, MDRD, and chronic kidney disease (CKD)-EPI equations. Patients were followed up at 90 days and 1 year after the event. RESULTS: In univariate analyses, age, active cancer, PE severity index (PESI), CrCl and eGFR, D-dimer value, and high-density lipoprotein level were found to be significantly associated with mortality in 90 days and 1 year. Additionally, body mass index was significant in the 1-year follow-up. CrCl by Cockcroft-Gault (90-day: area under the curve [AUC] 0.763; 1-year: AUC 0.718) demonstrated higher discriminatory power for predicting mortality than eGFR by the MDRD (AUC 0.686; AUC 0.609) and CKD-EPI (AUC 0.697; AUC 0.630) equations. In multivariate analyses, active cancer, CrCl by Cockcroft-Gault (90-day: hazard ratio [HR] 0.948, 95% CI 0.919-0.979; 1-year: HR 0.967, 95% CI 0.943-0.991), eGFR by CKD-EPI (90-day: HR 0.948, 95% CI 0.915-0.983; 1-year: HR 0.971, 95% CI 0.945-0.998) were found to be independent predictors of mortality. eGFR by MDRD, D-dimer, and PESI value were significant prognostic factors for 90-day mortality. CONCLUSION:Decreased renal function is a prognostic factor for increased all-cause mortality 90 days and 1 year after acute PE.
Authors: Bakhtawar K Mahmoodi; Ron T Gansevoort; Inger Anne Næss; Pamela L Lutsey; Sigrid K Brækkan; Nic J G M Veeger; Ellen E Brodin; Karina Meijer; Yingying Sang; Kunihiro Matsushita; Stein I Hallan; Jens Hammerstrøm; Suzanne C Cannegieter; Brad C Astor; Josef Coresh; Aaron R Folsom; John-Bjarne Hansen; Mary Cushman Journal: Circulation Date: 2012-09-13 Impact factor: 29.690
Authors: Frederick A Spencer; Robert J Goldberg; Darleen Lessard; George Reed; Cathy Emery; Joel M Gore; Luigi Pacifico; Jeff I Weitz Journal: Circ Cardiovasc Qual Outcomes Date: 2010-07-06
Authors: Frederikus A Klok; Wendy Zondag; Klaas W van Kralingen; Arie P J van Dijk; Jouke T Tamsma; Fenna H Heyning; Hubert W Vliegen; Menno V Huisman Journal: Am J Respir Crit Care Med Date: 2009-12-03 Impact factor: 21.405
Authors: Bakhtawar K Mahmoodi; Min Ki ten Kate; Femke Waanders; Nic J G M Veeger; Jan-Leendert P Brouwer; Liffert Vogt; Gerjan Navis; Jan van der Meer Journal: Circulation Date: 2007-12-24 Impact factor: 29.690
Authors: Keattiyoat Wattanakit; Mary Cushman; Catherine Stehman-Breen; Susan R Heckbert; Aaron R Folsom Journal: J Am Soc Nephrol Date: 2007-11-21 Impact factor: 10.121
Authors: Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen Journal: Circulation Date: 2006-02-07 Impact factor: 29.690
Authors: Rim Halaby; Christopher J Popma; Ander Cohen; Gerald Chi; Marcelo Rodrigues Zacarkim; Gonzalo Romero; Samuel Z Goldhaber; Russell Hull; Adrian Hernandez; Robert Mentz; Robert Harrington; Gregory Lip; Frank Peacock; James Welker; Ignacio Martin-Loeches; Yazan Daaboul; Serge Korjian; C Michael Gibson Journal: J Thromb Thrombolysis Date: 2015-01 Impact factor: 2.300
Authors: Valdis Ģībietis; Dana Kigitoviča; Barbara Vītola; Sintija Strautmane; Andris Skride Journal: Med Princ Pract Date: 2019-06-17 Impact factor: 1.927
Authors: Shinya Goto; Sylvia Haas; Walter Ageno; Samuel Z Goldhaber; Alexander G G Turpie; Jeffrey I Weitz; Pantep Angchaisuksiri; Joern Dalsgaard Nielsen; Gloria Kayani; Alfredo Farjat; Sebastian Schellong; Henri Bounameaux; Lorenzo G Mantovani; Paolo Prandoni; Ajay K Kakkar Journal: JAMA Netw Open Date: 2020-10-01